Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Eli Lilly Japan Helps Students Through Emotional Disorder Educational Programs

This article was originally published in PharmAsia News

Executive Summary

Eli Lilly Japan, along with other companies, has helped the Japanese nonprofit organization Association of Corporations and Education develop an educational program on emotional disorders targeting junior high and senior high school students. The development of the program also received advice and input from psychiatrists and patients. Pilot classes of the program were conducted at the end of November. Since then, the program has received accolades from experts in the field. Professor Mizuno of Toho University, a psychiatrist, states that from the point of early discovery and early treatment, teaching the program to junior and high school students who are prone to develop emotional disorders will be useful. The final compilation of materials for the program, including PowerPoint slides, DVD videos, teacher's manuals and videos of pilot classes, is scheduled to be completed by the middle of January. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066784

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel